CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 101 filers reported holding CARA THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $868,000 | +10.0% | 93,427 | -1.2% | 0.00% | 0.0% |
| Q3 2016 | $789,000 | +95.8% | 94,540 | +12.9% | 0.00% | 0.0% |
| Q2 2016 | $403,000 | -8.0% | 83,757 | +19.0% | 0.00% | 0.0% |
| Q1 2016 | $438,000 | -62.5% | 70,406 | +1.5% | 0.00% | 0.0% |
| Q4 2015 | $1,169,000 | +19.3% | 69,347 | +1.1% | 0.00% | 0.0% |
| Q3 2015 | $980,000 | +39.4% | 68,571 | +18.5% | 0.00% | 0.0% |
| Q2 2015 | $703,000 | +323.5% | 57,846 | +249.5% | 0.00% | – |
| Q1 2015 | $166,000 | +3.8% | 16,549 | +3.3% | 0.00% | – |
| Q4 2014 | $160,000 | +19.4% | 16,014 | 0.0% | 0.00% | – |
| Q3 2014 | $134,000 | -50.6% | 16,014 | +0.5% | 0.00% | – |
| Q2 2014 | $271,000 | -1.5% | 15,939 | +7.7% | 0.00% | – |
| Q1 2014 | $275,000 | – | 14,798 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,799,058 | $42,350,000 | 22.29% |
| Chescapmanager LLC | 1,314,603 | $19,890,000 | 2.42% |
| Prosight Management, LP | 294,041 | $4,449,000 | 2.06% |
| DAFNA Capital Management LLC | 261,442 | $3,956,000 | 1.18% |
| Cypress Capital Management LLC (WY) | 81,269 | $1,230,000 | 1.06% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $9,480,000 | 1.02% |
| Carmignac Gestion | 1,851,443 | $28,012,000 | 0.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,465,000 | $37,295,000 | 0.22% |
| Ikarian Capital, LLC | 301,700 | $4,565,000 | 0.20% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 689,899 | $10,438,000 | 0.20% |